- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05501990
Study on the Accessibility and Feasibility of Intelligent Applet for Health Intervention of Cancer Patients
December 20, 2023 updated by: lei huang, Ruijin Hospital
In the 5G era with the revolutionary improvement of network speed, digital medical care has brought great convenience to health services.
There is a lack of mobile medical data on cancer care worldwide.
We designed an applet based on mobile intelligent electronic devices with a doctor-patient dual interface for the perioperative management of cancer patients and verified its applicability in the general population.
This study aims to specifically improve the applet according to the characteristics of cancer patients, use it to accurately manage and intervene cancer patients, and establish a rapid doctor-patient communication platform, hoping to improve prognosis.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
800
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lei Huang, PhD, MD
- Phone Number: 0086 021 64370045
- Email: huangleizhenting@126.com
Study Locations
-
-
-
Shanghai, China, 200025
- Recruiting
- Ruijin Hospital,Shanghai Jiao Tong University School of Medicine
-
Contact:
- Lei Huang, PhD, MD
- Phone Number: 0086 021 64370045
- Email: huangleizhenting@126.com
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Sign and date informed consent;
- Commit to abide by the research procedures and cooperate with the implementation of the whole research process ;
- Can adhere to and cooperate with research intervention;
- Tumor patients;
- Patients/family members can use smart phones to access the Internet;
- Patients/family members have sufficient cognitive and reading ability;
- No mental illness;
- No serious visual impairment
Exclusion Criteria:
- Equipped with specific devices (such as cardiac pacemaker);
- Those who do not meet the conditions listed in the inclusion criteria.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Health intervention based on intelligent applet
Health interventions using electronic applet, including nutrition, psychology, and patient self-management components.
|
Patients are jointly managed by a MDT team based on the applet.
The supportive intervention based on the applet mainly includes three parts: Nutrition, psychology, and patient management which includes four main parts: Cancer patient education, self-management, patient community, and real-time communication.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Acceptability of the applet by cancer patients as assessed by questionnaire
Time Frame: 3 months
|
Investigated by a questionnaire with 33 questions, and compared with other mobile medical methods to explore the accessibility
|
3 months
|
|
Acceptability of the applet by medical oncology staff as assessed by questionnaire
Time Frame: 3 months
|
The questionnaire includes 22 questions, collecting information on attitude feedback, time input, and training cost of medical staff using the mobile medical applet
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Self-reported quality of life as assessed by ED-5Q-5L scale
Time Frame: 3 months
|
EQ-5D-5L is a set of standardized scales for measuring health status, including 5 dimensions (1-5 points for each dimension) and a VAS for overall assessment of health status.
Developed by the European Society for quality of life, it can provide a simple and universal health measurement method for clinical and economic evaluation.
|
3 months
|
|
Psychological status as assessed by the HADS scale
Time Frame: 3 months
|
Hospital Anxiety and Depression Scale (HADS): A self screening questionnaire composed of 7 anxiety subscales and 7 depression subscales.
The total score of each subscale is between 0 and 21.
The higher the total score, the more serious the anxiety or depression.
|
3 months
|
|
Symptom distress as assessed by the MD Anderson symptom scale
Time Frame: 3 months
|
Symptom distress is assessed with MD Anderson symptom scale, which is composed of 13 symptom severity and 6 symptom interference subscales.
It is used to assess the interference of symptoms to patients' daily life.
The item scores range from 1 to 10.
The higher the average score, the more serious the symptom.
|
3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Lei Huang, PhD, MD, Ruijin Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 1, 2023
Primary Completion (Estimated)
December 31, 2024
Study Completion (Estimated)
December 31, 2025
Study Registration Dates
First Submitted
August 10, 2022
First Submitted That Met QC Criteria
August 12, 2022
First Posted (Actual)
August 16, 2022
Study Record Updates
Last Update Posted (Estimated)
December 21, 2023
Last Update Submitted That Met QC Criteria
December 20, 2023
Last Verified
December 1, 2023
More Information
Terms related to this study
Other Study ID Numbers
- RJODLH-001
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Cancer
-
Cellworks Group Inc.RecruitingCancer | Relapsed Cancer | Refractory CancerUnited States
-
Yale UniversityNational Institute of Nursing Research (NINR); The Glimpse Group IncRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
University of Michigan Rogel Cancer CenterCompletedCancer Liver | Cancer Brain | Cancer Head &Neck | Cancer PelvisUnited States
-
Wake Forest University Health SciencesNational Cancer Institute (NCI); Atrium Health Wake Forest BaptistRecruitingCancer | Adolescent Cancer | Young Adult CancerUnited States
-
Vanderbilt-Ingram Cancer CenterEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedAdvanced Cancer | Relapsed Cancer | Refractory CancerUnited States
-
Second Affiliated Hospital of Soochow UniversityNot yet recruitingCancer | Solid Cancer
-
New Mexico Cancer Research AllianceOhio State University Comprehensive Cancer Center; H. Lee Moffitt Cancer Center...RecruitingCancer | Cancer RiskUnited States
-
Children's Hospital of PhiladelphiaCompletedCancer | Childhood CancerUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedStage III Pancreatic Cancer | Stage IIA Pancreatic Cancer | Stage IIB Pancreatic Cancer | Stage IV Gastric Cancer | Stage IVA Colorectal Cancer | Stage IVA Pancreatic Cancer | Stage IVB Colorectal Cancer | Stage IVB Pancreatic Cancer | Stage IIIA Gastric Cancer | Stage IIIB Gastric Cancer | Stage IIIC Gastric... and other conditionsUnited States
-
UNICANCERRecruitingAdvanced Breast Cancer | Advanced Gastric Cancer | Advanced Urothelial Cancer | Advanced Non Small Cell Lung Cancer (NSCLC)France
Clinical Trials on Health intervention based on intelligent applet
-
Beijing Anzhen HospitalNot yet recruitingCongenital Heart Disease | Aortic Aneurysm | Aortic Dissection | Heart Valve Disease | Coronary Artery Bypass Grafting | Cardiac Surgical ProceduresChina
-
The University of Hong KongRecruitingHard-to-Reach ElderlyHong Kong
-
University of RwandaUniversity of Ibadan; University of Peradeniya; Saveetha University; Usmanu Danfodiyo...Not yet recruitingOral Cancer | Health Education, Community | Digital Intervention | MHealth Application | MHealth InterventionRwanda, India, Nigeria, Sri Lanka
-
Pakistan Institute of Living and LearningCompleted
-
Qilu Hospital of Shandong UniversityNot yet recruiting
-
Universiti Putra MalaysiaNot yet recruitingOccupational Diseases | Occupational InjuriesMalaysia
-
Harbin Medical UniversityCompleted
-
Sun Yat-sen UniversityNational Natural Science Foundation of ChinaNot yet recruitingColorectal Cancer | Colonoscopy | First-degree RelativesChina
-
The Hong Kong Polytechnic UniversityFood and Health Bureau, Hong KongRecruiting
-
RANDSan Diego State University; California State University, Los AngelesCompletedPhysical ActivityUnited States